戻る Agendas
Session 0804 How is DAA Era Changing the Chronic HCV Management - Efficient Clinical Development
Session Chair(s)
Jessica Liu, MD
Senior Consultant
Beijing Taya Ltd, China
Speaker(s)
Hepatitis C Status and Umet Needs WEI-Shanghai 20150526-new
Lai Wei
PKU People's Hospital, China
Jinzi Wu
Ascletis BioScience Co., Ltd., China
Tao Wang, MD, PHD
China Food and Drug Administration (CFDA), China
Director of Chemical Medicine Evaluation office II